The Vaccine & Gene Therapy Institute of Florida (VGTI-FL) announced that it has selected Mel Rothberg to become its new Chief Operating Officer (COO). Mel Rothberg has participated over the last 35 years in the development of the South Florida bio-science industry and is presently co-Chairman of Bio Florida’s Southeast Chapter. He has held executive positions in the medical device, information technology, bio-pharmaceutical and healthcare sectors.
